MD Anderson Cancer Center Houston, TX - 77030

MD Anderson Cancer Center is categorized under Physicians Offices in Houston, TX .

MD Anderson Cancer Center was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6223100 by the NAICS.

If you are seeking more information, feel free to contact Leon Leach, Executive Vice President at the company’s single location by writing to 1515 Holcombe Boulevard Unit 207, Houston, Texas TX 77030 or by phoning (713) 792-2121. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: MD Anderson Cancer Center
Contact Person: Leon Leach, Executive Vice President
Address: 1515 Holcombe Boulevard Unit 207, Houston, Texas 77030
Phone Number: (713) 792-2121
Website Address: mdanderson.org
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 6223100
Share This Business:

MD Anderson Cancer Center was started in 0 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Leon Leach, Executive Vice President for inquiries that concern MD Anderson Cancer Center by calling the company number (713) 792-2121, as your correspondence is most welcome. Additionally, the physical location of the single location of MD Anderson Cancer Center can be found at the coordinates 29.706286,-95.397175 as well as the street address 1515 Holcombe Boulevard Unit 207 in Houston, Texas 77030.

For its online presence, you may visit MD Anderson Cancer Center’s website at mdanderson.org and engage with its social media outlets through on Twitter and on Facebook.